Spire Wealth Management grew its position in shares of ResMed Inc. (NYSE:RMD – Free Report) by 30,396.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 34,461 shares of the medical equipment provider’s stock after acquiring an additional 34,348 shares during the quarter. […]
Swiss National Bank cut its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 459,900 shares of the medical equipment provider’s stock after selling 12,700 shares during the period. Swiss National Bank owned 0.31% […]
Norden Group LLC trimmed its holdings in shares of ResMed Inc. (NYSE:RMD – Free Report) by 19.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,400 shares of the medical equipment provider’s stock after selling 336 shares during the period. Norden Group LLC’s holdings in […]
ResMed Inc. (ASX:RMD – Get Free Report) announced a interim dividend on Wednesday, May 1st, MarketIndexAU reports. Stockholders of record on Wednesday, June 12th will be given a dividend of 0.052 per share on Wednesday, June 12th. This represents a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, May 7th. This […]
ResMed (NYSE:RMD – Free Report) had its price target raised by Royal Bank of Canada from $187.00 to $200.00 in a report issued on Friday, Benzinga reports. The firm currently has a sector perform rating on the medical equipment provider’s stock. A number of other research analysts have also recently commented on the stock. Oppenheimer […]